001     282946
005     20251218103447.0
024 7 _ |a 10.5281/ZENODO.17113344
|2 doi
024 7 _ |a 10.5281/zenodo.17113344
|2 doi
037 _ _ |a DZNE-2025-01407
100 1 _ |a Rayan, Bader
|0 0000-0003-1408-2214
|b 0
245 _ _ |a Dataset: RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics, v1
260 _ _ |c 2025
|b Zenodo
336 7 _ |a MISC
|2 BibTeX
336 7 _ |a Dataset
|b dataset
|m dataset
|0 PUB:(DE-HGF)32
|s 1765985962_5349
|2 PUB:(DE-HGF)
336 7 _ |a Chart or Table
|0 26
|2 EndNote
336 7 _ |a Dataset
|2 DataCite
336 7 _ |a DATA_SET
|2 ORCID
336 7 _ |a ResearchData
|2 DINI
520 _ _ |a Amyloids, classically linked to neurodegenerative diseases, also play critical roles in infection and immunity. Phenol-soluble modulins (PSMs) from Staphylococcus aureus are virulent amyloids that contribute to cytotoxicity, immune modulation, and biofilm stability. PSMα3 forms cross-α amyloid fibrils and shares sequence and structural features with LL-37, a human host-defense peptide that assembles into α-helical structures. Here, we uncover RNA as a potent, context-dependent modulator of their aggregation and activity. RNA consistently reduces LL-37’s cytotoxicity toward human cells without compromising its antibacterial function, suggesting a selective host-protective mechanism. In contrast, RNA preserves PSMα3’s cytotoxic and antimicrobial activity over time, likely by promoting liquid–liquid phase separation (LLPS) and stabilizing bioactive fibrillar polymorphs, enabling S. aureus to fine-tune its virulence strategies. At higher concentrations, RNA drives both peptides toward distinct aggregated states, amorphous for LL-37 and fibrillar for PSMα3, underlying their divergent functional outcomes. The amyloid inhibitor EGCG abolishes the bioactivity of both PSMα3 and LL-37, overriding RNA’s modulatory effects. Together, our findings establish RNA as a key modulator of both virulent amyloids and host-defense peptides, with broad implications for microbial immune evasion, innate immunity, and amyloid-associated diseases. Moreover, they highlight phase transitions as a tunable mechanism for regulating peptide bioactivity and a promising therapeutic target across infectious and neurodegenerative conditions.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite
700 1 _ |a Barnea, Eilon
|b 1
700 1 _ |a Indig, Rinat
|b 2
700 1 _ |a Pantoja, Christian Felipe
|0 P:(DE-2719)2812808
|b 3
700 1 _ |a Gayk, Jesse
|b 4
700 1 _ |a Lupu-Haber, Yael
|0 0000-0002-2601-4123
|b 5
700 1 _ |a Upcher, Alexander
|0 0000-0002-0910-6552
|b 6
700 1 _ |a Argoetti, Amir
|0 0000-0002-0412-003X
|b 7
700 1 _ |a Larsen, Jacob
|0 0000-0002-6782-0594
|b 8
700 1 _ |a Buell, Alexander
|0 0000-0003-1161-3622
|b 9
700 1 _ |a Zweckstetter, Markus
|0 P:(DE-2719)2810591
|b 10
700 1 _ |a Landau, Meytal
|0 0000-0002-1743-3430
|b 11
773 _ _ |a 10.5281/zenodo.17113344
787 0 _ |a Rayan, Bader et.al.
|d Zenodo, 2025
|i RelatedTo
|0 DZNE-2025-01406
|r
|t Dataset: RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics, v2
909 C O |o oai:pub.dzne.de:282946
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2812808
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810591
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2025
920 1 _ |0 I:(DE-2719)1410001
|k AG Zweckstetter
|l Translational Structural Biology
|x 0
980 _ _ |a dataset
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1410001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21